Health Care/Hospital

Neurophth Therapeutics Further Expands Ocular Gene Therapy Expertise with Appointment of Qiutang Li, Ph.D., as Chief Scientific Officer

WUHAN, China and NEWARK, Del., Jan. 27, 2021 /PRNewswire/ -- Wuhan Neurophth Biotechnology Ltd., a fully-integrated genetic medicines company developing AAV-delivered gene therapies for the treatment of ocular diseases, today announced the appointment of Qiutang Li, Ph.D., as Chief Scientific Off...

2021-01-27 21:00 1768

MINISO Donates Over 2 Million Masks to North American Non-Profit Organizations and Colleges

GUANGZHOU, China, Jan. 27, 2021 /PRNewswire/ -- As part of its campaign in the fight against the COVID-19 pandemic, branded variety retailer MINISO (NYSE: MNSO) has donated more than 1 million masks to Get Us PPE and over 10,000 masks to colleges around the U.S. The masks will aid in protecting f...

2021-01-27 19:30 6859

Singapore-based Osteopore International Collaborates With Maastricht University Medical Centre To Develop Implant Solution That Prevents Leg Amputations

* Osteopore and Maastricht University Medical Centre has developed a first-of-its-kind, bioresorbable bone implant solution that prevents leg amputations in patients with severe lower leg fractures * Osteopore and National Additive Manufacturing Innovation Cluster have formed a partnership to...

2021-01-27 17:57 2085

Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device

TAIPEI, Jan. 27, 2021 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), a Taiwan publicly traded medical device company, is pleased to announce positive interim results of the EXPANDER-1 Clinical Study for its flagship product the XFLO™ Expander System, an innovative, minimally invasive Benign...

2021-01-27 17:41 2369

Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA

INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company's track record as a premiere CDO serv...

2021-01-27 08:26 6436

Biocytogen Subsidiary Eucure Biopharma Reports First Patient Enrolled in anti-CTLA4 Phase I Trial in China

BOSTON and BEIJING, Jan. 26, 2021 /PRNewswire/ -- Eucure Biopharma, a subsidiary of Biocytogen, announced the first patient enrollment for a Phase I clinical trial inChina to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of its anti-CTLA4 monoclonal antibody (YH001)...

2021-01-26 23:45 1520

Maypharm Announces New Product METOX on Times Square in New York

SEOUL, South Korea and NEW YORK, Jan. 26, 2021 /PRNewswire/ -- Maypharm announces new botulinum toxin, METOX onJanuary 26, 2021. METOX is an effective solution for smoothing any kind of wrinkles from moderate to severe, caused by daily active facial movements.

2021-01-26 17:00 1887

Samsung Biologics Reports 66% Increase in 2020 Revenue Achieving "1 Trillion Won" Target Sales

INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) reported its fourth quarter and full-year 2020 financial results indicating strong business performance, benefitting from increased sales across all plants and significant business agility and operating excelle...

2021-01-26 15:00 6683

I-Mab and MorphoSys Announce First Patient Dosed in U.S. Phase 1 Study of TJ210/MOR210 in Patients with Advanced Cancer

SHANGHAI, China and PLANEGG/MUNICH, Germany, Jan. 25, 2021 /PRNewswire/ -- I-Mab (Nasdaq: IMAB), and MorphoSys (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) today announced that the first patient has been dosed in a phase 1 dose escalation study to evaluate the safety, tolerabili...

2021-01-26 05:05 3673

BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine

MAINZ, Germany and SHANGHAI, China, 25 Jan. 2021 /PRNewswire/ -- BioNTech SE  (Nasdaq: BNTX, "BioNTech" or "the Company") andShanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "Group"; Stock Code: 600196.SH, 02196.HK) today announced that according to the Food and Health Bureau of ...

2021-01-26 01:18 6353

VolitionRx Limited Opens its New Manufacturing Facility in Belgium

AUSTIN, Texas, Jan. 25, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the opening of "Silver One", its 10,000 square foot dedicated manufacturing facility located on the same science park as its Research and Development laboratory in Isnes,Belgium. Vol...

2021-01-25 21:45 8507

China Biologic Announces Extraordinary General Meeting of Shareholders

BEIJING, Jan. 25, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that it has called an extraordinary general meeting of shareholders (the "EGM...

2021-01-25 21:44 9682

Dada Group secures necessities supply in Shijiazhuang during COVID-19 outbreak -- Chinese National TV Reported

SHANGHAI, Jan. 24, 2021 /PRNewswire/ -- Dada Group (Nasdaq: DADA) ("Dada" or the "Company"),China's leading local on-demand delivery and retail platform, is working with retailers and brands to provide safe, contactless on-demand delivery service inShijiazhuang, Hebei Province, to combat with the...

2021-01-25 11:29 4231

New Zealand team creates world-first innovation in the fight against Coronavirus

AUCKLAND, New Zealand, Jan. 22, 2021 /PRNewswire/ -- Datamine, a New Zealand based AI company, has createdëlarm: a personal early warning indicator for viral infection, includingCoronavirus. The ëlarm system overcomes what is arguably our greatest obstacle – viral spread by asymptomatic people wh...

2021-01-23 00:41 3236

Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021

NANPING, China, Jan. 22, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months endedSeptember 30, 2020 and provided the guida...

2021-01-22 21:00 11507

DWHP Announces Extension of The Expiration Time of Its Tender Offer

PARK CITY, Utah, Jan. 22, 2021 /PRNewswire/ -- DW Healthcare Partners V, L.P. (" DWHP"), announced today that it is extending the expiration time of its previously announced cash tender offer (the "Tender Offer") in the Offer to Purchase datedDecember 21, 2020 ("Offer to Purchase") for all of the ...

2021-01-22 12:34 9832

Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for Patients with Severe COVID-19

TAIPEI and SAN DIEGO, Jan. 21, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that the first patient has enrolled into an investi...

2021-01-22 12:00 2155

Sasakawa Leprosy (Hansen's Disease) Initiative Generates Awareness in Buildup to World Leprosy Day 2021

TOKYO, Jan. 21, 2021 /PRNewswire/ -- With the approach of World Leprosy Day on January 31, 2021, Sasakawa Leprosy (Hansen's Disease) Initiative has created a number of opportunities to amplify the voices of persons affected by leprosy and highlight the issues they face.

2021-01-21 22:00 1949

China Jo-Jo Drugstores Hosts the First Suppliers Conference in China

HANGZHOU, China, Jan. 21, 2021 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the...

2021-01-21 21:30 7224

The 5th China Health Industry Development Forum Held in Panzhihua

PANZHIHUA, China, Jan. 20, 2021 /PRNewswire/ -- The 5th China Health Industry Development Forum, themed with "What Can the Health Industry Do for a Healthy China", was hosted in the Chinese city of Panzhihua onJanuary 18. At the forum that was organized by the Panzhihua Municipal People's Gover...

2021-01-20 20:02 1730
1 ... 297298299300301302303 ... 306